The US largely imports pharmaceutical products from India and Europe.

U.S. President Donald Trump announces 100% tariff on branded pharmaceutical imports, pushing for U.S. manufacturing, impacting India's $20 billion industry.

The 100% tariff on pharmaceuticals, 25% on trucks, and 30% on furniture will come into effect on October 1.